RGC

Companies
NASDAQ
Regencell Bioscience Holdings Ltd.
Health Care
Price Chart
Overview

About RGC

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Market Cap
$61.2M
Volume
6.0M
Avg. Volume
6.7M
P/E Ratio
Dividend Yield
0.00%
Employees
12.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Risk & Correlation Analysis
Market Correlation
0.24
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for RGC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, RGC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$61.2M
Volume6.0M
P/E Ratio
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 9, 2017
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how RGC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025